跳至主要内容
临床试验/NCT01723631
NCT01723631终止不适用

Study Multicenter, Controlled, Prospective, Non-randomized Test to Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis

Nantes University Hospital11 个研究点 分布在 1 个国家目标入组 189 人开始时间: 2012年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
189
试验地点
11
主要终点
Evaluate the diagnostic performance of myelin-TRAP assay for Multiple Sclerosis

研究概览

简要总结

The objective of this project is to characterize the response TRAP positive patients with Multiple Sclerosis (MS) and to evaluate the sensitivity and specificity of the method in order to develop a second time as a diagnostic tool in this disease. We plan to analyze the response TRAP over a hundred patients with various clinical stages SEP (relapsing, progressive forms) and compared to healthy controls,

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •These criteria depend on the subgroup belongs to the patient.
  • •Signed consent
  • •Membership of a social security system

排除标准

  • •Whatever the patient group or control:
  • •Processing immunosuppressive.
  • •Processing by a monoclonal antibody.
  • •Previous treatment with an immunosuppressant for a significant period of time (more than 6 months of oral treatment, more than 6 cycles of cyclophosphamide over 3 cures mitoxantrone).
  • •Carcinomatous pathology known evolving.
  • •People under guardianship.
  • •Pregnant women.
  • •Patients not motivated to study. Known patients with anemia (hemoglobin <10g/100ml)

研究组 & 干预措施

Control 2

Other

Patients with central or peripheral neurological non-inflammatory, non-autoimmune.

干预措施: Trap Myelin Test (Device)

Control 3

Other

Patients having an autoimmune pathology

干预措施: Trap Myelin Test (Device)

Relapsing Multiple Sclerosis- group 2

Other

Multiple sclerosis defined according to the criteria of McDonald, relapsing Patient under treatment immunomodulator for at least 6 months.

干预措施: Trap Myelin Test (Device)

Relapsing Multiple Sclerosis- group 1

Other

Definite multiple sclerosis according to the McDonald criteria, relapsing Patient innocent of thorough treatment or treatment immunomodulator stopped for at least 6 months.

干预措施: Trap Myelin Test (Device)

secondary progressive multiple sclerosis- Group 3

Other

Multiple sclerosis defined according to the criteria of McDonald, secondary progressive multiple sclerosis

干预措施: Trap Myelin Test (Device)

primary progressive multiple sclerosis- group 4

Other

Multiple sclerosis defined according to the criteria of McDonald, primary progressive multiple sclerosis

干预措施: Trap Myelin Test (Device)

control 1

Other

healthy volunteers

干预措施: Trap Myelin Test (Device)

结局指标

主要结局

Evaluate the diagnostic performance of myelin-TRAP assay for Multiple Sclerosis

时间窗: 2 years

The main criterion corresponds to the area under the curve ROC (Receiver operating characteristic). The curve ROC is a graphic representation of the existing relation between the sensibility and the specificity of a test, calculated for all the values possible thresholds. The performance of the test TRAP-myéline will thus be estimated by means of the area calculated under this curve

次要结局

  • Determine the best cut-off rate of myelin-Trap and evaluate the sensitivity and specificity associated(2 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验